Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,029 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Elucidating the Biological Mechanisms Linking Depressive Symptoms With Type 2 Diabetes in Men: The Longitudinal Effects of Inflammation, Microvascular Dysfunction, and Testosterone.
Tully PJ, Baumeister H, Martin S, Atlantis E, Jenkins A, Januszewski A, OʼLoughlin P, Taylor A, Wittert GA; Florey Adelaide Male Ageing Study. Tully PJ, et al. Among authors: jenkins a. Psychosom Med. 2016 Feb-Mar;78(2):221-32. doi: 10.1097/PSY.0000000000000263. Psychosom Med. 2016. PMID: 26575859
Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial.
Petrie JR, Chaturvedi N, Ford I, Brouwers MCGJ, Greenlaw N, Tillin T, Hramiak I, Hughes AD, Jenkins AJ, Klein BEK, Klein R, Ooi TC, Rossing P, Stehouwer CDA, Sattar N, Colhoun HM; REMOVAL Study Group. Petrie JR, et al. Among authors: jenkins aj. Lancet Diabetes Endocrinol. 2017 Aug;5(8):597-609. doi: 10.1016/S2213-8587(17)30194-8. Epub 2017 Jun 11. Lancet Diabetes Endocrinol. 2017. PMID: 28615149 Free PMC article. Clinical Trial.
Testosterone therapy to prevent type 2 diabetes mellitus in at-risk men (T4DM): Design and implementation of a double-blind randomized controlled trial.
Wittert G, Atlantis E, Allan C, Bracken K, Conway A, Daniel M, Gebski V, Grossmann M, Hague W, Handelsman DJ, Inder W, Jenkins A, Keech A, McLachlan R, Robledo K, Stuckey B, Yeap BB. Wittert G, et al. Among authors: jenkins a. Diabetes Obes Metab. 2019 Apr;21(4):772-780. doi: 10.1111/dom.13601. Epub 2019 Jan 4. Diabetes Obes Metab. 2019. PMID: 30520208
Telephone call reminders did not increase screening uptake more than SMS reminders: a recruitment study within a trial.
Bracken K, Keech A, Hague W, Kirby A, Robledo KP, Allan C, Conway A, Daniel M, Gebski V, Grossmann M, Handelsman DJ, Inder W, Jenkins A, McLachlan R, Stuckey B, Yeap BB, Wittert G. Bracken K, et al. Among authors: jenkins a. J Clin Epidemiol. 2019 Aug;112:45-52. doi: 10.1016/j.jclinepi.2019.04.009. Epub 2019 Apr 30. J Clin Epidemiol. 2019. PMID: 31051248 Clinical Trial.
A high-volume, low-cost approach to participant screening and enrolment: Experiences from the T4DM diabetes prevention trial.
Bracken K, Keech A, Hague W, Allan C, Conway A, Daniel M, Gebski V, Grossmann M, Handelsman DJ, Inder WJ, Jenkins A, McLachlan R, Robledo KP, Stuckey B, Yeap BB, Wittert G. Bracken K, et al. Among authors: jenkins a. Clin Trials. 2019 Dec;16(6):589-598. doi: 10.1177/1740774519872999. Epub 2019 Oct 3. Clin Trials. 2019. PMID: 31581816
2,029 results